Page 37 - Ipid Management News Today

Recommendations to help doctors distinguish between true side effects of statins and those arising from patients’ expectations launched by international expert group.

Starting lipid-lowering treatment earlier in life may reduce cardiovascular risk in patients with familial hypercholesterolemia vs those who do not, a meta-analysis suggests.

The product of fasting plasma triglyceride and glucose levels (TyG index) plus waist-to-height ratio accounted for 68.6% of the risk for incident metabolic syndrome in 590 Chinese adults.

Assessing the prevalence of metabolic syndrome in patients with PsA remains a challenge because the definition varies across studies, according to the authors.

A better understanding of the most common injuries associated with nonfatal TBI-related hospitalizations could help identify strategies to prevent these avoidable injuries.

Only around 50% of people at risk of cardiovascular disease receive lifestyle support say researchers, who suggest that patients are missing out on proven methods of reducing risk.

A new draft guidance from the US Preventive Services Task Force uses more recent data to update its 2016 document on when to consider moderate-intensity statin therapy for primary prevention.

Using a deep-learning model, Australian researchers utilized brain MRI studies from over 37,000 UK Biobank participants to develop an estimate of white matter brain age.

Although many patients with diabetes also have cardiovascular disease, researchers have found a "shocking underuse" of medications to lower cholesterol, blood pressure and glucose in new observational data.

Evidence to date suggests that five key micronutrients may boost the failing myocardium and improve symptoms of heart failure, according to a new review. Randomized trials should be next, researchers say.